H.R. 1199 · 118th Congress

Facilitating Innovative Nuclear Diagnostics Act of 2023

Introduced on Feb 27, 2023 by Neal P. Dunn (R-FL-2). 47 cosponsors, 27 of them from another party. Latest action (May 16, 2024): Forwarded by Subcommittee to Full Committee by Voice Vote.

Stage
Introduced
Introduced
Feb 27, 2023
Cosponsors
47
27 from the other party
Policy area
Health

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. 2Reported by committee
  3. 3Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Official title

To amend title XVIII of the Social Security Act to ensure equitable payment for, and preserve Medicare beneficiary access to, diagnostic radiopharmaceuticals under the Medicare hospital outpatient prospective payment system.

Subjects

  • Health care costs and insurance
  • Medical tests and diagnostic methods
  • Medicare
  • Radiation

Summary

The Congressional Research Service has not summarized this measure yet.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

Neal P. DunnR-FL-2Sponsor

Democrats · 27

Republicans · 20

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. Feb 27, 2023Introduced in House
  2. Feb 27, 2023Introduced in House
  3. Feb 27, 2023 · HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  4. Feb 27, 2023 · HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  5. Mar 10, 2023 · HouseReferred to the Subcommittee on Health.
  6. May 16, 2024 · HouseSubcommittee Consideration and Mark-up Session Held
  7. May 16, 2024 · HouseForwarded by Subcommittee to Full Committee by Voice Vote.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Who lobbied on it

Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.

  1. Society of Nuclear Medicine and Molecular Imaging13 reports
    $490K reported (all issues)
  2. Alzheimer's Association11 reports
    $10.5M reported (all issues)
  3. AHRA: The Association for Medical Imaging Management5 reports
    $100K reported (all issues)
  4. Blue Earth Diagnostics, Inc.5 reports
    $160K reported (all issues)
  5. CARDINAL HEALTH INC.5 reports
    $2.3M reported (all issues)Federal contractor: CARDINAL HEALTH 200, LLC$276.6M in contracts, FY2026AI match · 100%
  6. GE HEALTHCARE TECHNOLOGIES INC.5 reports
    $770K reported (all issues)
  7. Life Molecular Imaging (f/k/a Piramal Imaging Limited)5 reports
    $100K reported (all issues)
  8. Medical Imaging & Technology Alliance (MITA)5 reports
    $300K reported (all issues)
  9. NATIONAL ELECTRICAL MANUFACTURERS ASSOCIATION5 reports
  10. Siemens Healthineers (fka Varian Medical Systems, Inc.)5 reports
    $300K reported (all issues)
  11. The Michael J. Fox Foundation For Parkinson's Research5 reports
    $380K reported (all issues)
  12. LANTHEUS HOLDINGS INC4 reports
    $765K reported (all issues)
  13. NOVARTIS CORPORATION4 reports
    $3.4M reported (all issues)Federal contractor: NOVARTIS PHARMACEUTICALS CORPORATION$36.2M in contracts, FY2026AI match · 100%
  14. RefleXion Medical4 reports
    $240K reported (all issues)
  15. SIEMENS MEDICAL SOLUTIONS USA INC.4 reports
    $2.7M reported (all issues)Federal contractor: SIEMENS MEDICAL SOLUTIONS USA, INC.AI match · 100%
  16. GE Healthcare3 reports
    $180K reported (all issues)Federal contractor: GE HEALTHCARE CARIBBEAN EXPORT LLC$336.2K in contracts, FY2026AI match · 98%
  17. BWX TECHNOLOGIES, INC1 report
    $120K reported (all issues)
  18. National Association of Nuclear Pharmacies1 report

Reports filed in 2023, 2024, 2025, 2026.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 5, 2026 · loaded Oct 5, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
  • Money and votes are shown side by side; neither explains the other.